Celltrion USA Signs Express Scripts Deal: FDA-Approved ZYMFENTRA

 


Celltrion USA has just announced a new partnership with Express Scripts, a major pharmacy benefit manager in the United States. This agreement, effective April 4, 2024, will make ZYMFENTRA Preferred Brand Access available on the Express Scripts National Preferred Formulary, benefiting 21.9 million insured lives. Express Scripts will now offer ZYMFENTRA™ (infliximab-dyyb) to plan participants, providing them with access to this FDA-approved treatment option for chronic diseases. This collaboration is a significant step towards improving access to care for millions of patients in need.


More Information : https://www.techdogs.com/tech-news/pr-newswire/celltrion-usa-signs-agreement-with-express-scripts-for-its-therapy-for-autoimmune-diseases-including-the-first-fda-approved-subcutaneous-infliximab-zymfentra

Comments

Post a Comment

Popular posts from this blog

Aon Unveils $350M Program for Ukraine Recovery

Image
  Aon plc, a prominent global professional services firm, has unveiled a groundbreaking $350M insurance program in collaboration with the U.S. International Development Finance Corporation to enhance insurance capabilities and drive new capital investment for economic recovery in Ukraine. As a major player in the Ukrainian market, Aon has spearheaded a comprehensive $50M reinsurance facility, in partnership with DFC and the Ukraine Ministry for Development of Economy and Trade, to facilitate the issuance of on-the-ground war risk policies for businesses in Ukraine. Additionally, Aon and DFC have jointly developed a $300M war risk insurance program tailored for Ukraine's health care and agriculture sectors. Eric Andersen, president of Aon, emphasized the importance of protecting capital through this innovative program with the U.S. International Development Finance Corporation to stimulate investment in Ukraine during a critical period. The initiative aims to bolster the local insur...
Read more

E&R Engineering Debuts Advanced Solutions at Semicon SEA 2024

Image
  E&R Engineering Corp., the leading provider of advanced laser and plasma solutions from Taiwan, will be attending Semicon SEA 2024, the feast in the Semiconductor industry, held in Kuala Lumpur, Malaysia. With their 30 years of experience in the semiconductor industry, E&R has developed a wide range of plasma and laser technologies. They will be showcasing their latest solutions at the event, which include: 1. Plasma Dicing - E&R offers a unique hybrid solution that combines laser grooving and plasma dicing. This allows for precise control of dice lanes ranging from 10um to 30um. In addition to equipment manufacturing, E&R also provides a convenient one-stop-shop dicing service to process wafers into small dies of various shapes, such as hexagonal, circular, or MPR pattern. 2. Advanced Packaging - E&R specializes in integrating self-developed optics modules and advanced laser systems to provide a laser drilling solution for 2.5D/3D packaging. Their solution of...
Read more

Cloud Computing Trends 2025

Image
  When you gaze at the clouds drifting in the sky, what do you perceive? A world of endless possibilities, right? Their shapes are ever-changing, evolving gracefully as they stretch across the horizon. They are in a constant state of flux, with new formations appearing at every moment. No matter how they transform, they always contribute to the larger tapestry of the sky, giving it depth and meaning. This dynamic nature is what makes clouds so captivating, serving as a reminder that our surroundings are also in a state of change—bringing with it new opportunities. The same holds true for cloud computing, which is perpetually evolving and influencing technology. Nowadays, it’s not merely about storing data; it’s about how businesses harness the flow of information, adapting and expanding to meet new challenges and demands. As we look ahead to 2025, just as clouds shift and adapt, cloud computing is reshaping our lives and work, opening up new avenues for businesses, technologists, a...
Read more